Clin2
NCT07105202Possibly a fitRecruiting

Shorter weaning from ventilator with levosimendan

Mechanical VentilationWeaning Failure

Treatments studied

Part of Lungs & breathing clinical trials.

This study tests if a heart medication called levosimendan helps people get off the breathing machine (ventilator) faster. It's for people who have been on a ventilator for more than 48 hours and have already tried and failed to breathe on their own.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
250 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You've been on a breathing machine for more than 2 days (48 hours).
  • You've tried to breathe on your own but couldn't (failed a spontaneous breathing trial).
  • You are 18 years or older.
  • If you're a woman under 60, you'll need a negative pregnancy test before starting.
  • You cannot have certain heart, kidney, or liver conditions that would make the study drug unsafe.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07003672Recruiting
Weaning from ventilator: a lung measurement study

This study looks at people who have a tracheostomy and have been on a breathing machine for at least two weeks. Researchers want to see if certain lung measurements can help predict how easy or hard it will be to come off the ventilator.

Taipei
NCT06683781Recruiting
Breathing machine settings and weaning success study

This study looks at how breathing machine settings and monitoring can help predict if a patient will successfully come off the ventilator. It may help doctors choose better settings for patients who are ready to try breathing on their own.

Buenos Aires
NCT07262723Not yet recruiting· Phase 2/Phase 3
Levosimendan for severe heart failure symptoms

This trial tests a medicine called levosimendan to see if it helps people with severe heart failure who still feel breathless at rest despite standard treatment. It may improve heart function and reduce symptoms.

Chittagong
NCT04020263Recruiting· Phase 3
Levosimendan early treatment vs placebo for cardiogenic shock

This study tests whether giving levosimendan early (a heart-strengthening medicine) improves outcomes compared with placebo, on top of standard inotropic support, in people with cardiogenic shock. It mainly looks at whether patients have fewer serious complications or deaths.

Strasbourg, Bas-Rhin
NCT06142474Recruiting· Phase 3
SGLT2 inhibitors for heart failure patients during ventilator weaning

This trial tests a heart failure medication (SGLT2 inhibitor) to help people with heart failure who are on a breathing machine (ventilator) get better and come off the machine faster. It is for patients with a specific type of heart failure where the heart pumps weakly (EF ≤ 40%).

Taipei
NCT07594418Not yet recruiting
Personalized ventilator weaning for people with chronic conditions

This study tests a personalized approach to help people with chronic heart or lung conditions come off a breathing machine (ventilator) more safely and successfully. The approach uses your specific health profile to guide when and how to remove the ventilator.

Hear when a new Mechanical Ventilation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.